Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved crawled time : 15:30 save search
PPL Corporation subsidiary Rhode Island Energy receives regulatory approval for planned spending to strengthen network safety, reliability and resilience
Published: 2024-04-02 (Crawled : 15:30) - prnewswire.com
PPL | News M | $26.62 0.76% 0.0% 3.3M
|
Utilities
|
| O: -0.11%
H: 0.87%
C: 0.04%
energy approval corporation network
Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve
Published: 2024-04-02 (Crawled : 15:30) - biospace.com/
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -0.18%
H: 0.47%
C: 0.12%
fda device approval heart
FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’sAgency to convene an advisory committee to consider the drug
Published: 2024-03-08 (Crawled : 15:30) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: -2.29%
fda drug approval treatment
ESGEN Acquisition Shareholders Approve Sunergy Renewables Deal
Published: 2024-03-07 (Crawled : 15:30) - spacfeed.com
SEEL | $0.338 1.81% -3.11% 280K
|
Health Technology
|
| O: 6.19%
H: 5.0%
C: -3.33%
acquisition deal
Willis Sustainable Fuels (UK) Limited Approved for Construction of Sustainable Aviation Fuel (“SAF”) Refinery at Teesworks, UK
Published: 2024-03-05 (Crawled : 15:30) - globenewswire.com
WLFC S | $50.34 1.49% 1.47% 6.4K
|
Finance
|
| O: -0.67%
H: 2.76%
C: -0.38%
approved construction
Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon
Published: 2024-03-01 (Crawled : 15:30) - biospace.com/
BSX | $67.42 -0.8% -0.53% 5.9M
|
Health Technology
|
| O: 0.21%
H: 1.58%
C: 1.18%
fda approval
Sizzle Acquisition Shareholders Approve European Lithium Merger
Published: 2024-02-27 (Crawled : 15:30) - spacfeed.com
ENGN | $14.41 -8.45% -9.23% 45K
|
n/a
|
| O: -3.72%
H: 4.0%
C: 2.0%
lithium acquisition
OceanTech I Shareholders Approve Regentis Deal as Final Redemptions Reach 99.9%
Published: 2024-02-14 (Crawled : 15:30) - spacfeed.com
ATMU A | $31.09 -3.45% -0.29% 1.7M
|
n/a
|
| O: -1.21%
H: 1.81%
C: -0.09%
SCRM S | $10.77 -0.09% -0.09% 6.3M
|
n/a
|
| O: 0.19%
H: 0.0%
C: -0.19%
redemptions reach deal
IBM BOARD APPROVES REGULAR QUARTERLY CASH DIVIDEND
Published: 2024-01-30 (Crawled : 15:30) - prnewswire.com
IBM | $181.47 -0.89% -0.53% 2.9M
|
Technology Services
|
| O: 0.3%
H: 0.5%
C: 0.09%
Garden Veggie™ Snacks Launches Kid-Loved and Parent-Approved Flavor Burst™ Tortilla Chips
Published: 2024-01-29 (Crawled : 15:30) - prnewswire.com
HAIN | $5.89 2.26% 2.04% 2.3M
|
Consumer Non-Durables
|
| O: 0.0%
H: 0.64%
C: 0.55%
snacks
FDA Decisions: Theratechnologies Must Address Several Questions in CRL for Li...
Published: 2024-01-25 (Crawled : 15:30) - biospace.com/
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: 0.73%
H: 0.3%
C: -0.39%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 0.47%
H: 1.04%
C: 0.93%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.27%
H: 0.0%
C: 0.0%
fda
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VCA-894A, a Novel Antisense Oligonucleotide Candidate for the Treatment of Charcot-Marie-Tooth Disease, Type 2S
Published: 2024-01-23 (Crawled : 15:30) - biospace.com/
VNDA | $4.97 -5.15% -5.43% 3.6M
|
Health Technology
|
| O: 2.11%
H: 1.03%
C: -4.13%
vca-894 fda drug candidate approval treatment pharmaceuticals
FDA Decisions: Merck's Keytruda Wins 39th Overall Approval, Third in Cervical...
Published: 2024-01-15 (Crawled : 15:30) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
| Email alert
Add to watchlist
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
| Email alert
Add to watchlist
fda keytruda
Hennessy Capital Investment VI Shareholders Approve 8-Month Extension
Published: 2024-01-11 (Crawled : 15:30) - spacfeed.com
HCVI | $10.48 -0.1% 0.1% 3.1K
|
n/a
|
| O: 0.86%
H: 0.0%
C: -1.89%
extension
Denali Capital Shareholders Approve Longevity Biomedical Deal
Published: 2024-01-10 (Crawled : 15:30) - spacfeed.com
SAML | $0.0244 -0.41% -21.69% 140K
|
|
| O: 46.55%
H: 1.18%
C: -17.65%
deal
Pono Capital Three Shareholders Approve Horizon Aircraft Deal
Published: 2024-01-05 (Crawled : 15:30) - spacfeed.com
CPT 4 | $95.29 -0.03% -0.3% 450K
|
Finance
|
| O: -0.81%
H: 1.72%
C: 1.21%
deal
StoneBridge Acquisition Extends Termination Date Following DigiAsia Deal Approval
Published: 2024-01-03 (Crawled : 15:30) - spacfeed.com
SIF 4 | $3.05 -0.97% 0.0% 760
|
Electronic Technology
|
| O: -0.27%
H: 2.39%
C: -2.7%
approval acquisition deal
Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
Published: 2023-12-12 (Crawled : 15:30) - biospace.com/
PFE A | $25.39 -0.12% 0.24% 31M
|
Health Technology
|
| O: -0.07%
H: 0.84%
C: -0.14%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 3.27%
H: 0.0%
C: 0.0%
acquisition
FDA Decisions: Novartis, Lilly Win Approvals in PNH, Blood Cancers
Published: 2023-12-07 (Crawled : 15:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.66%
H: 0.0%
C: 0.0%
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: 0.03%
H: 5.6%
C: 3.1%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.61%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.19%
H: 0.0%
C: 0.0%
fda blood
The European Commission Approves Label Update for TAKHZYRO® (lanadelumab), Expanding Its Use to a Broader Group of Paediatric Patients with Recurrent Attacks of Hereditary Angioedema (HAE)
Published: 2023-11-17 (Crawled : 15:30) - prnewswire.com
TAK | News | $13.16 0.08% 0.53% 1.2M
|
Health Technology
|
| O: 1.75%
H: 0.32%
C: -0.07%
takhzyro label update group
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.